Literature DB >> 25427047

Muir-Torre syndrome.

Feriyl Bhaijee1, Alexandra S Brown.   

Abstract

Muir-Torre syndrome (MTS) is a rare autosomal-dominant genodermatosis characterized by sebaceous neoplasms and one or more visceral malignancies. Sebaceous tumors include sebaceous adenoma and carcinoma, which may be solitary or multiple. Visceral malignancies most often arise in the colorectum and endometrium. Because a subset of patients with phenotypic MTS will have germline mutations in the DNA mismatch repair genes hMSH2 and hMLH1, MTS is considered a phenotypic subtype of Lynch syndrome (also known as hereditary nonpolyposis colorectal cancer syndrome), in which inherited defects in DNA mismatch repair genes result in microsatellite instability. Pathologists have an important role in the early detection and initial diagnosis of MTS: identification of at-risk individuals allows appropriate screening and surveillance for visceral malignancies, thereby reducing morbidity and mortality. Herein, we describe the clinicopathologic features of MTS.

Entities:  

Mesh:

Year:  2014        PMID: 25427047     DOI: 10.5858/arpa.2013-0301-RS

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  10 in total

Review 1.  A Guide to Yellow Oral Mucosal Entities: Etiology and Pathology.

Authors:  Duane R Schafer; Sarah H Glass
Journal:  Head Neck Pathol       Date:  2019-01-31

2.  Lynch syndrome with exclusive skin involvement: time to consider a molecular definition?

Authors:  Alessandro Vaisfeld; Martina Calicchia; Maria Grazia Pomponi; Emanuela Lucci-Cordisco; Luca Reggiani-Bonetti; Maurizio Genuardi
Journal:  Fam Cancer       Date:  2019-10       Impact factor: 2.375

Review 3.  Parotid Sebaceous Carcinoma in Patient with Muir Torre Syndrome, Caused by MSH2 Mutation.

Authors:  Iyer Vishwas Neelakantan; Silvana Di Palma; C E T Smith; A McCoombe
Journal:  Head Neck Pathol       Date:  2015-11-17

Review 4.  Syndrome-Associated Tumors by Organ System.

Authors:  Raul S Gonzalez; Nicole D Riddle
Journal:  J Pediatr Genet       Date:  2016-03-09

Review 5.  Inherited skin tumour syndromes.

Authors:  Sarah Brown; Paul Brennan; Neil Rajan
Journal:  Clin Med (Lond)       Date:  2017-12       Impact factor: 2.659

6.  Upper tract urothelial carcinomas: frequency of association with mismatch repair protein loss and lynch syndrome.

Authors:  Holly L Harper; Jesse K McKenney; Brandie Heald; Andrew Stephenson; Steven C Campbell; Thomas Plesec; Cristina Magi-Galluzzi
Journal:  Mod Pathol       Date:  2016-10-07       Impact factor: 7.842

Review 7.  Diagnosis of Lynch Syndrome and Strategies to Distinguish Lynch-Related Tumors from Sporadic MSI/dMMR Tumors.

Authors:  Julie Leclerc; Catherine Vermaut; Marie-Pierre Buisine
Journal:  Cancers (Basel)       Date:  2021-01-26       Impact factor: 6.639

8.  Urothelial Carcinoma Recurrence in an Ileal Neobladder Nine Years after Primary Surgery with Muir-Torre Syndrome.

Authors:  Floryn Cherbanyk; Marc Prod'homme; Edgardo Pezzetta; Bernard Chevaux; Anass Anaye; Jean-Joseph Boillat
Journal:  Case Rep Urol       Date:  2016-03-30

9.  Muir-Torre Syndrome Presenting as Sebaceous Adenocarcinoma and Invasive MSH6-Positive Colorectal Adenocarcinoma.

Authors:  Sunil Tulpule; Hiyam Ibrahim; Mohamed Osman; Shoaib Zafar; Romana Kanta; Gregory Shypula; Mohammed A Islam; Shuvendu Sen; Abdalla Yousif
Journal:  Case Rep Oncol       Date:  2016-02-04

10.  Lrig1 Expression in Human Sebaceous Gland Tumors.

Authors:  Jöri Pünchera; Laurent Barnes; Gürkan Kaya
Journal:  Dermatopathology (Basel)       Date:  2016-06-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.